Publications by authors named "Krishna Polu"

Claim this Profile
L
Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial.
Manish Saxena, Luke Laffin, Claudio Borghi, Beatriz Fernandez Fernandez, Jalal K Ghali, Krishna Polu

JAMA· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CD6/ALCAM pathway promotes lupus nephritis via T cell-mediated responses.
Samantha A Chalmers, Rajalakshmy Ayilam Ramachandran, Sayra J Garcia, Evan Der, Leal Herlitz, Krishna R Polu

J Clin Invest· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probody therapeutics for targeting antibodies to diseased tissue.
Krishna R Polu, Henry B Lowman

Expert Opin Biol Ther· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginesatide in patients with anemia undergoing hemodialysis.
Steven Fishbane, Brigitte Schiller, Francesco Locatelli, Adrian C Covic, Robert Provenzano, Krishna R Polu

N Engl J Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.
Iain C Macdougall, Robert Provenzano, Amit Sharma, Bruce S Spinowitz, Rebecca J Schmidt, Krishna R Polu

N Engl J Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients.
Anatole Besarab, Steven N Zeig, Edouard R Martin, Pablo E Pergola, Frederick C Whittier, Krishna R Polu

BMC Nephrol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-finding study of peginesatide for anemia correction in chronic kidney disease patients.
Iain C Macdougall, Andrzej Wiecek, Beatriz Tucker, Magdi Yaqoob, Ashraf Mikhail, Krishna R Polu

Clin J Am Soc Nephrol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
John J V McMurray, Inder S Anand, Rafael Diaz, Aldo P Maggioni, Christopher O'Connor, Krishna R Polu

Eur J Heart Fail· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPHS2 variation in focal and segmental glomerulosclerosis.
Stephen J Tonna, Alexander Needham, Krishna Polu, Andrea Uscinski, Gerald B Appel

BMC Nephrol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical problem-solving. Needle in a haystack.
Krishna R Polu, Myles Wolf

N Engl J Med· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRPC6 is a glomerular slit diaphragm-associated channel required for normal renal function.
Jochen Reiser, Krishna R Polu, Clemens C Möller, Peter Kenlan, Mehmet M Altintas

Nat Genet· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis